LeMaitre Vascular, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5255582018
USD
84.22
0.9 (1.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
61.05
64.23
59.87
55.72
54.82
55.85
53.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
61.05
64.23
59.87
55.72
54.82
55.85
53.48
Raw Material Cost
16.53
20.70
19.87
17.13
19.11
18.85
18.29
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.30
1.30
1.29
0.20
0.00
0.00
0.00
Selling and Distribution Expenses
21.23
23.85
23.28
22.05
18.91
18.33
19.20
Other Expenses
0.17
0.22
0.28
0.34
0.37
0.43
0.41
Total Expenditure (Excl Depreciation)
40.73
48.09
47.24
42.80
41.67
41.47
41.58
Operating Profit (PBDIT) excl Other Income
20.299999999999997
16.1
12.6
12.9
13.100000000000001
14.399999999999999
11.899999999999999
Other Income
3.56
3.23
2.90
1.37
1.40
1.13
0.92
Operating Profit (PBDIT)
26.48
22.02
18.08
16.71
16.98
17.89
15.20
Interest
1.30
1.30
1.29
0.20
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
-0.06
0.00
0.00
-0.02
Gross Profit (PBDT)
44.51
43.54
40.00
38.59
35.71
37.00
35.19
Depreciation
2.61
2.65
2.55
2.42
2.43
2.38
2.38
Profit Before Tax
22.57
18.07
14.24
14.02
14.55
15.51
12.80
Tax
5.21
4.29
3.23
2.84
3.41
3.68
2.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.36
13.78
11.01
11.18
11.14
11.83
9.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.36
13.78
11.01
11.18
11.14
11.83
9.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.36
13.78
11.01
11.18
11.14
11.83
9.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
378.92
362.69
347.57
337.29
331.07
319.53
308.50
Earnings per share (EPS)
0.75
0.6
0.48
0.49
0.49
0.52
0.44
Diluted Earnings per share
0.75
0.6
0.48
0.49
0.49
0.52
0.44
Operating Profit Margin (Excl OI)
33.27%
25.13%
21.09%
23.19%
23.98%
25.75%
22.25%
Gross Profit Margin
41.26%
32.25%
28.05%
29.5%
30.97%
32.03%
28.38%
PAT Margin
28.44%
21.45%
18.39%
20.07%
20.32%
21.17%
18.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 11.31% vs 15.61% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 56.76% vs 48.00% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 46.79% vs 34.48% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of LeMaitre Vascular, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
61.05
213.10
-152.05
-71.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
61.05
213.10
-152.05
-71.35%
Raw Material Cost
16.53
70.70
-54.17
-76.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.30
1.50
-0.20
-13.33%
Selling and Distribution Expenses
21.23
129.30
-108.07
-83.58%
Other Expenses
0.17
2.41
-2.24
-92.95%
Total Expenditure (Excl Depreciation)
40.73
225.60
-184.87
-81.95%
Operating Profit (PBDIT) excl Other Income
20.31
-12.50
32.81
262.48%
Other Income
3.56
0.10
3.46
3,460.00%
Operating Profit (PBDIT)
26.48
1.90
24.58
1,293.68%
Interest
1.30
1.50
-0.20
-13.33%
Exceptional Items
0.00
-316.70
316.70
100.00%
Gross Profit (PBDT)
44.51
142.40
-97.89
-68.74%
Depreciation
2.61
14.30
-11.69
-81.75%
Profit Before Tax
22.57
-330.60
353.17
106.83%
Tax
5.21
-0.10
5.31
5,310.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
17.36
-330.50
347.86
105.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.36
-330.50
347.86
105.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.36
-330.50
347.86
105.25%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
378.92
388.10
-9.18
-2.37%
Earnings per share (EPS)
0.75
-3.57
4.32
121.01%
Diluted Earnings per share
0.75
-3.57
4.32
121.01%
Operating Profit Margin (Excl OI)
33.27%
-5.87%
0.00
39.14%
Gross Profit Margin
41.26%
-148.43%
0.00
189.69%
PAT Margin
28.44%
-155.09%
0.00
183.53%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 6.10 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.98% vs 7.18% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 11.31% vs 15.61% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.74 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 26.09% vs 25.45% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 56.76% vs 48.00% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.29 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.81% vs 23.68% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 46.79% vs 34.48% in Sep 2024

Quarterly - Interest
Interest 0.13 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.27%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024